Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.
    2.

    Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.

    Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.

    Filaria J. 2003 Oct 24;2 Suppl 1:S2.

    PMID:
    14975059
    [PubMed - as supplied by publisher]
    Free PMC Article
    3.

    Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis.

    Haselow NJ, Akame J, Evini C, Akongo S.

    Filaria J. 2003 Oct 24;2 Suppl 1:S10.

    PMID:
    14975067
    [PubMed - as supplied by publisher]
    Free PMC Article
    4.

    A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.

    Addiss DG, Rheingans R, Twum-Danso NA, Richards FO.

    Filaria J. 2003 Oct 24;2 Suppl 1:S9.

    PMID:
    14975066
    [PubMed - as supplied by publisher]
    Free PMC Article
    5.

    Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.

    Awadzi K.

    Filaria J. 2003 Oct 24;2 Suppl 1:S6.

    PMID:
    14975063
    [PubMed - as supplied by publisher]
    Free PMC Article
    6.

    Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.

    Higazi TB, Klion AD, Boussinesq M, Unnasch TR.

    Filaria J. 2004 Jun 29;3(1):4.

    PMID:
    15225348
    [PubMed - as supplied by publisher]
    Free PMC Article
    8.

    Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.

    Twum-Danso NA.

    Filaria J. 2003 Oct 24;2 Suppl 1:S3.

    PMID:
    14975060
    [PubMed - as supplied by publisher]
    Free PMC Article
    9.

    Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.

    Mackenzie CD, Geary TG, Gerlach JA.

    Filaria J. 2003 Oct 24;2 Suppl 1:S5.

    PMID:
    14975062
    [PubMed - as supplied by publisher]
    Free PMC Article
    10.

    Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.

    Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.

    Filaria J. 2005 Apr 7;4(1):2.

    PMID:
    15817124
    [PubMed - as supplied by publisher]
    Free PMC Article
    11.

    The Mectizan Donation Program (MDP).

    Thylefors B.

    Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44.

    PMID:
    18718154
    [PubMed - indexed for MEDLINE]
    12.

    [Ivermectin].

    Boussinesq M.

    Med Trop (Mars). 2005;65(1):69-79. Review. French.

    PMID:
    15903082
    [PubMed - indexed for MEDLINE]
    13.

    Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.

    Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.

    Parasitology. 2004 Nov;129(Pt 5):613-26.

    PMID:
    15552406
    [PubMed - indexed for MEDLINE]
    14.

    Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

    Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP.

    Filaria J. 2003 Oct 24;2 Suppl 1:S4.

    PMID:
    14975061
    [PubMed - as supplied by publisher]
    Free PMC Article
    15.

    Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.

    Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

    Parasitology. 2006 Jul;133(Pt 1):101-9.

    PMID:
    16764737
    [PubMed - indexed for MEDLINE]
    16.

    Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).

    Kamgno J, Pion SD, Tejiokem MC, Twum-Danso NA, Thylefors B, Boussinesq M.

    Trans R Soc Trop Med Hyg. 2007 Aug;101(8):777-85. Epub 2007 May 24.

    PMID:
    17531279
    [PubMed - indexed for MEDLINE]
    17.

    Ivermectin: does P-glycoprotein play a role in neurotoxicity?

    Edwards G.

    Filaria J. 2003 Oct 24;2 Suppl 1:S8.

    PMID:
    14975065
    [PubMed - as supplied by publisher]
    Free PMC Article
    18.

    Loiasis: African eye worm.

    Padgett JJ, Jacobsen KH.

    Trans R Soc Trop Med Hyg. 2008 Oct;102(10):983-9. Epub 2008 May 7. Review.

    PMID:
    18466939
    [PubMed - indexed for MEDLINE]
    19.

    Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?

    Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.

    Parasitology. 2006 Jun;132(Pt 6):843-54. Epub 2006 Feb 10.

    PMID:
    16469200
    [PubMed - indexed for MEDLINE]
    20.

    Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control.

    Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M.

    Filaria J. 2004 Aug 6;3(1):7.

    PMID:
    15298709
    [PubMed - as supplied by publisher]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk